Study Compares Surgical Techniques for Crohn Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 1, 2024 -- For patients undergoing open or laparoscopic resection of the small bowel or strictureplasty for Crohn disease (CD), small bowel resection is associated with the longest length of stay and increased odds of postoperative wound complications, according to a study published online July 29 in the International Journal of Colorectal Disease.
Oguz AZ. Aras, from Guthrie Robert Packer Hospital in Sayre, Pennsylvania, and colleagues queried the American College of Surgeons national surgical quality registry database between 2015 and 2020 for all patients undergoing open or laparoscopic resection of small bowel or strictureplasty for CD. Data were included for 2,578 patients: 87 underwent small bowel resection, 5 percentm underwent resection with strictureplasty, and 8 percent underwent strictureplasty alone.
The researchers found that combined surgery (resection plus strictureplasty) was associated with the longest operative time. The longest length of hospital stay, highest incidence of superficial/deep wound infection (44 percent), and highest incidence of sepsis (3.5 percent) were seen for patients undergoing small bowel resection. Compared with combined surgery and strictureplasty, small bowel resection was associated with higher odds of wound complication (odds ratios, 2.09 and 1.9, respectively).
"Measured outcomes for all three surgical techniques were comparable for 30-day related reoperation and readmission," the authors write. "Likewise, all three surgical approaches showed similar outcomes for patient disposition on hospital discharge."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization
WEDNESDAY, Aug. 28, 2024 -- Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization...
Televisit Outpatient Care Feasible for Inflammatory Bowel Disease
FRIDAY, Aug. 23, 2024 -- Televisit-delivered outpatient care for inflammatory bowel disease (IBD) is not associated with a higher risk for IBD-related hospitalization, according...
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
WEDNESDAY, July 17, 2024 -- For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.